Market Cap ₹1476 Cr.
Stock P/E 48.3
P/B 10.8
Current Price ₹90.5
Book Value ₹ 8.4
Face Value 1
52W High ₹105
Dividend Yield 0%
52W Low ₹ 58.5
KMC Speciality Hospitals (India) Ltd is a healthcare offerings and pharmacy organization. The Company is engaged in providing medical and healthcare services. It offers a number of services through its departments and care centres, which consist of Cardiac Science, which treats the disorders of the heart, which include diagnosis and treatment of congenital heart irregularities, coronary artery diseases, heart failure and valvular heart diseases, and electrophysiology; Gastroenterology, which affords intestinal medication and surgical operation that includes transplants; Geriatrics, which affords treatment for social and mental problems along with age related medical troubles; Nephrology and Urology Science, which gives total renal care to the patient; Orthopedics, which gives treatment for different parts of the musculoskeletal system, the bones, joints, muscular tissues, tendons and ligaments, and Pediatrics, which gives total care and revival to neonates, babies,and kids.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 33 | 38 | 33 | 35 | 40 | 40 | 41 | 41 | 42 | 49 |
Other Income | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 |
Total Income | 33 | 39 | 33 | 36 | 40 | 41 | 42 | 42 | 43 | 50 |
Total Expenditure | 24 | 26 | 25 | 26 | 29 | 30 | 30 | 31 | 31 | 35 |
Operating Profit | 9 | 13 | 8 | 10 | 11 | 11 | 12 | 12 | 12 | 15 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 8 | 11 | 6 | 8 | 9 | 9 | 10 | 9 | 9 | 12 |
Provision for Tax | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 |
Profit After Tax | 6 | 8 | 4 | 6 | 7 | 6 | 7 | 7 | 7 | 9 |
Adjustments | 0 | 0 | -0 | 0 | -0 | 0 | 0 | 0 | -0 | 0 |
Profit After Adjustments | 6 | 8 | 4 | 6 | 7 | 6 | 7 | 7 | 7 | 9 |
Adjusted Earnings Per Share | 0.3 | 0.5 | 0.3 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.6 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 29 | 32 | 36 | 43 | 55 | 71 | 82 | 96 | 103 | 136 | 156 | 173 |
Other Income | 0 | 3 | 0 | 1 | 0 | 0 | 2 | 1 | 3 | 2 | 3 | 5 |
Total Income | 29 | 35 | 37 | 44 | 55 | 71 | 84 | 98 | 105 | 138 | 159 | 177 |
Total Expenditure | 23 | 30 | 31 | 35 | 42 | 56 | 66 | 75 | 80 | 99 | 114 | 127 |
Operating Profit | 6 | 5 | 6 | 9 | 13 | 15 | 18 | 23 | 25 | 40 | 45 | 51 |
Interest | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
Depreciation | 1 | 4 | 4 | 3 | 3 | 4 | 4 | 5 | 6 | 7 | 8 | 8 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 1 | -2 | 0 | 4 | 8 | 10 | 12 | 17 | 18 | 32 | 36 | 40 |
Provision for Tax | 0 | -1 | 0 | 1 | 3 | 3 | 4 | 5 | 5 | 8 | 9 | 9 |
Profit After Tax | 1 | -0 | 0 | 3 | 5 | 7 | 9 | 12 | 13 | 24 | 27 | 30 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 1 | -0 | 0 | 3 | 5 | 7 | 9 | 12 | 13 | 24 | 27 | 30 |
Adjusted Earnings Per Share | 0.1 | -0 | 0 | 0.2 | 0.3 | 0.4 | 0.5 | 0.7 | 0.8 | 1.5 | 1.6 | 1.8 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 15% | 18% | 17% | 18% |
Operating Profit CAGR | 13% | 25% | 25% | 22% |
PAT CAGR | 13% | 31% | 31% | 39% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 49% | 28% | 48% | 46% |
ROE Average | 27% | 27% | 26% | 20% |
ROCE Average | 27% | 29% | 30% | 24% |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 13 | 10 | 10 | 13 | 24 | 30 | 39 | 51 | 63 | 87 | 114 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 13 | 12 | 9 | 6 | 3 | 10 | 8 | 6 | 26 | 20 | 40 |
Other Non-Current Liabilities | 2 | 2 | 2 | 0 | -5 | -4 | -3 | 11 | 18 | 26 | 38 |
Total Current Liabilities | 6 | 9 | 9 | 10 | 10 | 12 | 12 | 12 | 13 | 20 | 23 |
Total Liabilities | 34 | 33 | 31 | 29 | 33 | 49 | 56 | 80 | 120 | 152 | 214 |
Fixed Assets | 29 | 28 | 25 | 23 | 24 | 36 | 36 | 39 | 74 | 75 | 84 |
Other Non-Current Assets | 3 | 2 | 3 | 4 | 4 | 4 | 8 | 23 | 20 | 34 | 78 |
Total Current Assets | 3 | 3 | 3 | 3 | 4 | 8 | 13 | 18 | 26 | 42 | 52 |
Total Assets | 34 | 33 | 31 | 29 | 33 | 49 | 56 | 80 | 120 | 152 | 214 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 3 | 0 | 0 | 0 | 0 | 1 | 0 | 2 | 1 | 2 | 2 |
Cash Flow from Operating Activities | 7 | 4 | 5 | 6 | 10 | 12 | 16 | 11 | 26 | 29 | 32 |
Cash Flow from Investing Activities | -7 | -2 | -1 | -1 | -4 | -19 | -9 | -8 | -43 | -29 | -48 |
Cash Flow from Financing Activities | -3 | -1 | -5 | -5 | -5 | 6 | -5 | -4 | 18 | -1 | 16 |
Net Cash Inflow / Outflow | -3 | 0 | -0 | -0 | 1 | -1 | 1 | -1 | 1 | -0 | 0 |
Closing Cash & Cash Equivalent | 0 | 0 | 0 | 0 | 1 | 0 | 2 | 1 | 2 | 2 | 2 |
# | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 0.06 | -0.02 | 0.01 | 0.2 | 0.33 | 0.41 | 0.53 | 0.72 | 0.78 | 1.45 | 1.64 |
CEPS(Rs) | 0.12 | 0.24 | 0.24 | 0.4 | 0.52 | 0.64 | 0.79 | 1.02 | 1.16 | 1.86 | 2.11 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 0.82 | 0.62 | 0.63 | 0.82 | 1.47 | 1.86 | 2.4 | 3.11 | 3.88 | 5.32 | 6.96 |
Core EBITDA Margin(%) | 20.06 | 5.3 | 15.77 | 18.89 | 22.76 | 20.27 | 19.8 | 22.21 | 22.25 | 27.38 | 26.51 |
EBIT Margin(%) | 17.68 | 2.06 | 5.91 | 13.38 | 17.15 | 15.26 | 16.69 | 18.54 | 18.73 | 24.31 | 23.83 |
Pre Tax Margin(%) | 4.73 | -4.85 | 0.34 | 9.53 | 14.57 | 13.87 | 14.99 | 17.36 | 17.58 | 23.59 | 23.11 |
PAT Margin (%) | 3.24 | -0.93 | 0.34 | 7.55 | 9.77 | 9.41 | 10.46 | 12.21 | 12.45 | 17.44 | 17.13 |
Cash Profit Margin (%) | 7.05 | 12.3 | 10.79 | 15.26 | 15.59 | 14.88 | 15.57 | 17.35 | 18.46 | 22.23 | 22.04 |
ROA(%) | 2.87 | -0.88 | 0.38 | 10.63 | 17.14 | 16.3 | 16.4 | 17.24 | 12.81 | 17.48 | 14.59 |
ROE(%) | 7.24 | -2.52 | 1.22 | 27.24 | 28.6 | 24.43 | 24.78 | 26.17 | 22.42 | 31.61 | 26.65 |
ROCE(%) | 17.95 | 2.37 | 8.53 | 23.92 | 34.73 | 28.63 | 29.11 | 33.09 | 25.85 | 32.44 | 27.32 |
Receivable days | 15.05 | 13.34 | 10.82 | 11.65 | 10.83 | 10.74 | 9.23 | 7.27 | 8.28 | 8.17 | 9.27 |
Inventory Days | 8.29 | 8.4 | 7.37 | 5.79 | 4.33 | 3.49 | 3.58 | 5.99 | 7.07 | 4.86 | 4.86 |
Payable days | 96.8 | 145.73 | 168.07 | 155.97 | 129.77 | 128.17 | 143.12 | 127.26 | 106.85 | 94.22 | 93.91 |
PER(x) | 67.6 | 0 | 375 | 39.98 | 39.63 | 44.01 | 29.22 | 17.39 | 27.82 | 38.25 | 35.16 |
Price/Book(x) | 4.73 | 4.41 | 4.56 | 9.59 | 8.83 | 9.63 | 6.44 | 4.03 | 5.61 | 10.46 | 8.27 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 2.73 | 1.89 | 1.65 | 3.25 | 3.97 | 4.3 | 3.1 | 2.1 | 3.55 | 6.62 | 6.06 |
EV/Core EBITDA(x) | 12.71 | 12.36 | 10.08 | 15.43 | 17.28 | 20.74 | 14.25 | 8.87 | 14.37 | 22.76 | 21.09 |
Net Sales Growth(%) | 46.47 | 10.61 | 13.75 | 17.27 | 28.81 | 28.89 | 16.4 | 16.92 | 6.71 | 32.58 | 14.47 |
EBIT Growth(%) | 86.25 | -87.11 | 226.14 | 165.58 | 65.12 | 14.64 | 27.36 | 29.88 | 7.79 | 72.1 | 12.21 |
PAT Growth(%) | 16.49 | -131.63 | 141.86 | 2493.79 | 66.61 | 24.24 | 29.4 | 36.42 | 8.83 | 85.66 | 12.49 |
EPS Growth(%) | 16.43 | -131.53 | 141.99 | 2493.42 | 66.57 | 24.25 | 29.39 | 36.42 | 8.83 | 85.66 | 12.49 |
Debt/Equity(x) | 1.17 | 1.62 | 1.34 | 0.77 | 0.26 | 0.48 | 0.26 | 0.15 | 0.43 | 0.31 | 0.39 |
Current Ratio(x) | 0.46 | 0.3 | 0.28 | 0.31 | 0.41 | 0.68 | 1.01 | 1.43 | 2.08 | 2.18 | 2.3 |
Quick Ratio(x) | 0.33 | 0.22 | 0.2 | 0.24 | 0.35 | 0.63 | 0.94 | 1.25 | 1.94 | 2.08 | 2.2 |
Interest Cover(x) | 1.37 | 0.3 | 1.06 | 3.47 | 6.64 | 11.01 | 9.8 | 15.67 | 16.33 | 33.73 | 32.93 |
Total Debt/Mcap(x) | 0.25 | 0.37 | 0.29 | 0.08 | 0.03 | 0.05 | 0.04 | 0.04 | 0.08 | 0.03 | 0.05 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 12.23 | 12.23 | 12.23 | 12.23 | 12.23 | 12.23 | 12.23 | 12.23 | 12.23 | 12.23 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 4.08 | 4.08 | 4.08 | 4.08 | 4.08 | 4.08 | 4.08 | 4.08 | 4.08 | 4.08 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 16.31 | 16.31 | 16.31 | 16.31 | 16.31 | 16.31 | 16.31 | 16.31 | 16.31 | 16.31 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About